Race Does Not Impact Pancreatic Cancer Treatment and Survival in an Equal Access Federal Health Care System

Background Black patients with pancreatic adenocarcinoma (PDAC) have been reported to undergo surgical resection less frequently and to have a shorter overall survival duration than white patients. We sought to determine whether disparities in clinical management and overall survival exist between black and white patients with PDAC treated in an equal access health care system.